STOCK TITAN

[Form 4] HealthEquity, Inc Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Form 144 filed for Upstart Holdings, Inc. (UPST) details the proposed sale of 5,000 common shares on or around 07/08/2025 through Charles Schwab & Co. at an aggregate market value of $400,210. The shares were acquired the same day via a cashless exercise of employee stock options; therefore, no new shares are issued and the transaction is non-dilutive.

The filing lists prior insider activity by Scott Darling over the last three months, totaling 26,115 shares sold for gross proceeds of $1.44 million. Including the newly proposed trade, cumulative insider sales reach 31,115 shares. Relative to the company’s outstanding share count of 95.1 million, the upcoming 5,000-share sale represents approximately 0.005% of shares outstanding, indicating minimal mechanical impact on float or liquidity.

While the dollar amounts are modest in the context of Upstart’s market capitalization, continued insider selling may draw investor attention, particularly given ongoing macro uncertainty affecting fintech valuations. The Form 144 also affirms that the seller possesses no undisclosed material adverse information, satisfying Rule 144 requirements.

Il modulo 144 presentato per Upstart Holdings, Inc. (UPST) descrive la proposta vendita di 5.000 azioni ordinarie intorno al 08/07/2025 tramite Charles Schwab & Co., per un valore di mercato complessivo di 400.210 $. Le azioni sono state acquisite lo stesso giorno tramite un esercizio senza esborso di opzioni azionarie dipendenti; di conseguenza, non sono state emesse nuove azioni e la transazione non è diluitiva.

La documentazione riporta attività precedenti di insider da parte di Scott Darling negli ultimi tre mesi, con la vendita totale di 26.115 azioni per un ricavo lordo di 1,44 milioni di $. Considerando anche la nuova vendita proposta, le vendite cumulative degli insider raggiungono 31.115 azioni. Rispetto al numero totale di azioni in circolazione, pari a 95,1 milioni, la vendita imminente di 5.000 azioni rappresenta circa lo 0,005% delle azioni in circolazione, indicando un impatto minimo sulla liquidità o sul flottante.

Nonostante gli importi in dollari siano modesti rispetto alla capitalizzazione di mercato di Upstart, la continua vendita da parte degli insider potrebbe attirare l'attenzione degli investitori, soprattutto considerando l'incertezza macroeconomica che influenza le valutazioni fintech. Il modulo 144 conferma inoltre che il venditore non possiede informazioni materiali negative non divulgate, rispettando i requisiti della Regola 144.

El formulario 144 presentado para Upstart Holdings, Inc. (UPST) detalla la propuesta venta de 5,000 acciones comunes alrededor del 08/07/2025 a través de Charles Schwab & Co., con un valor de mercado agregado de $400,210. Las acciones fueron adquiridas el mismo día mediante un ejercicio sin desembolso de opciones sobre acciones para empleados; por lo tanto, no se emitieron nuevas acciones y la transacción no es dilutiva.

La presentación lista actividad previa de insider por parte de Scott Darling en los últimos tres meses, con un total de 26,115 acciones vendidas por ingresos brutos de $1.44 millones. Incluyendo la nueva venta propuesta, las ventas acumuladas de insiders alcanzan 31,115 acciones. En relación con el número total de acciones en circulación de 95.1 millones, la próxima venta de 5,000 acciones representa aproximadamente el 0.005% de las acciones en circulación, indicando un impacto mecánico mínimo en el flotante o la liquidez.

Aunque los montos en dólares son modestos en el contexto de la capitalización de mercado de Upstart, la continua venta por parte de insiders puede atraer la atención de los inversores, especialmente dada la incertidumbre macroeconómica que afecta las valoraciones fintech. El formulario 144 también confirma que el vendedor no posee información material adversa no divulgada, cumpliendo con los requisitos de la Regla 144.

Upstart Holdings, Inc. (UPST)에 대해 제출된 144 양식은 2025년 7월 8일경 Charles Schwab & Co.를 통해 5,000주 보통주 매각을 제안하며, 총 시장 가치는 400,210달러입니다. 해당 주식은 같은 날 직원 주식 옵션의 현금 없는 행사를 통해 취득되었으므로, 신규 주식 발행은 없으며 거래는 희석 효과가 없습니다.

해당 제출서류에는 지난 3개월간 Scott Darling의 내부자 거래 내역이 포함되어 있으며, 총 26,115주를 매도하여 총 수익은 144만 달러입니다. 이번 제안된 거래를 포함하면 내부자 매도 누적 주식 수는 31,115주에 달합니다. 회사의 총 발행 주식 수 9,510만 주 대비 이번 5,000주 매도는 약 0.005%의 유통 주식에 해당하여 유통 주식 수나 유동성에 미치는 영향은 미미합니다.

달러 금액은 Upstart의 시가총액에 비해 적은 편이지만, 지속적인 내부자 매도는 특히 핀테크 평가에 영향을 미치는 거시경제 불확실성 상황에서 투자자들의 관심을 끌 수 있습니다. 144 양식은 또한 판매자가 미공개 중요 부정적 정보를 보유하지 않음을 확인하여 규칙 144 요건을 충족함을 명시합니다.

Le formulaire 144 déposé pour Upstart Holdings, Inc. (UPST) détaille la vente proposée de 5 000 actions ordinaires aux alentours du 08/07/2025 via Charles Schwab & Co., pour une valeur marchande totale de 400 210 $. Les actions ont été acquises le même jour via un exercice sans décaissement d’options d’achat d’actions des employés ; par conséquent, aucune nouvelle action n’a été émise et la transaction n’est pas dilutive.

Le dépôt liste les activités antérieures d’initiés par Scott Darling au cours des trois derniers mois, totalisant 26 115 actions vendues pour un produit brut de 1,44 million de $. En incluant la nouvelle transaction proposée, les ventes cumulées des initiés atteignent 31 115 actions. Par rapport au nombre total d’actions en circulation de 95,1 millions, la vente imminente de 5 000 actions représente environ 0,005 % des actions en circulation, ce qui indique un impact mécanique minimal sur le flottant ou la liquidité.

Bien que les montants en dollars soient modestes dans le contexte de la capitalisation boursière d’Upstart, la poursuite des ventes d’initiés pourrait attirer l’attention des investisseurs, notamment en raison de l’incertitude macroéconomique persistante affectant les valorisations fintech. Le formulaire 144 confirme également que le vendeur ne détient aucune information matérielle défavorable non divulguée, respectant ainsi les exigences de la règle 144.

Das Formular 144 für Upstart Holdings, Inc. (UPST) beschreibt den geplanten Verkauf von 5.000 Stammaktien um den 08.07.2025 herum über Charles Schwab & Co. zu einem Gesamtmarktwert von 400.210 $. Die Aktien wurden am selben Tag durch eine barlose Ausübung von Mitarbeiteraktienoptionen erworben; daher wurden keine neuen Aktien ausgegeben und die Transaktion ist nicht verwässernd.

Die Einreichung listet frühere Insider-Aktivitäten von Scott Darling in den letzten drei Monaten auf, mit insgesamt 26.115 verkauften Aktien und Bruttoerlösen von 1,44 Millionen $. Einschließlich des neu vorgeschlagenen Verkaufs belaufen sich die kumulativen Insider-Verkäufe auf 31.115 Aktien. Im Verhältnis zur ausstehenden Aktienzahl des Unternehmens von 95,1 Millionen entsprechen die bevorstehenden 5.000 Aktien etwa 0,005 % der ausstehenden Aktien, was auf eine minimale mechanische Auswirkung auf den Streubesitz oder die Liquidität hinweist.

Obwohl die Dollarbeträge im Kontext der Marktkapitalisierung von Upstart bescheiden sind, könnte der fortgesetzte Insiderverkauf die Aufmerksamkeit der Investoren auf sich ziehen, insbesondere angesichts der anhaltenden makroökonomischen Unsicherheit, die die Bewertungen im Fintech-Bereich beeinflusst. Das Formular 144 bestätigt zudem, dass der Verkäufer keine nicht offengelegten wesentlichen negativen Informationen besitzt und damit die Anforderungen der Regel 144 erfüllt.

Positive
  • Non-dilutive cashless option exercise means no increase in shares outstanding.
  • Sale represents only 0.005% of total shares, posing minimal liquidity impact.
Negative
  • Continued insider selling (31,115 shares in ~3 months) may signal reduced insider confidence.
  • Repeated sales could create negative sentiment among investors despite limited quantitative impact.

Insights

TL;DR Insider plans to sell 5k shares after prior 26k sales; small size but sustained selling trend.

The proposed 5,000-share sale equates to roughly 0.005% of UPST’s outstanding stock—mechanically immaterial. However, Form 144 shows a pattern: Scott Darling has liquidated 26,115 shares since late April. Persistent insider selling, even at small percentages, can signal caution to investors assessing management’s conviction, especially for a high-beta fintech whose valuation hinges on growth expectations. Because the shares stem from an option exercise, there is no dilution risk. Overall, the filing is not financially material but is worth monitoring for sentiment.

TL;DR Routine Rule 144 filing; negligible float impact, modest optics risk from repeat sales.

Rule 144 compliance looks straightforward—broker handling, option exercise documentation, and representation of no undisclosed adverse information. The transaction size is modest, suggesting personal liquidity management rather than strategic divestment. Nonetheless, serial sales by the same insider within a short window can attract governance scrutiny. Investors should track whether future 10b5-1 plans or additional Form 4 filings emerge, as clustering sales might weigh on market perception even if legally routine.

Il modulo 144 presentato per Upstart Holdings, Inc. (UPST) descrive la proposta vendita di 5.000 azioni ordinarie intorno al 08/07/2025 tramite Charles Schwab & Co., per un valore di mercato complessivo di 400.210 $. Le azioni sono state acquisite lo stesso giorno tramite un esercizio senza esborso di opzioni azionarie dipendenti; di conseguenza, non sono state emesse nuove azioni e la transazione non è diluitiva.

La documentazione riporta attività precedenti di insider da parte di Scott Darling negli ultimi tre mesi, con la vendita totale di 26.115 azioni per un ricavo lordo di 1,44 milioni di $. Considerando anche la nuova vendita proposta, le vendite cumulative degli insider raggiungono 31.115 azioni. Rispetto al numero totale di azioni in circolazione, pari a 95,1 milioni, la vendita imminente di 5.000 azioni rappresenta circa lo 0,005% delle azioni in circolazione, indicando un impatto minimo sulla liquidità o sul flottante.

Nonostante gli importi in dollari siano modesti rispetto alla capitalizzazione di mercato di Upstart, la continua vendita da parte degli insider potrebbe attirare l'attenzione degli investitori, soprattutto considerando l'incertezza macroeconomica che influenza le valutazioni fintech. Il modulo 144 conferma inoltre che il venditore non possiede informazioni materiali negative non divulgate, rispettando i requisiti della Regola 144.

El formulario 144 presentado para Upstart Holdings, Inc. (UPST) detalla la propuesta venta de 5,000 acciones comunes alrededor del 08/07/2025 a través de Charles Schwab & Co., con un valor de mercado agregado de $400,210. Las acciones fueron adquiridas el mismo día mediante un ejercicio sin desembolso de opciones sobre acciones para empleados; por lo tanto, no se emitieron nuevas acciones y la transacción no es dilutiva.

La presentación lista actividad previa de insider por parte de Scott Darling en los últimos tres meses, con un total de 26,115 acciones vendidas por ingresos brutos de $1.44 millones. Incluyendo la nueva venta propuesta, las ventas acumuladas de insiders alcanzan 31,115 acciones. En relación con el número total de acciones en circulación de 95.1 millones, la próxima venta de 5,000 acciones representa aproximadamente el 0.005% de las acciones en circulación, indicando un impacto mecánico mínimo en el flotante o la liquidez.

Aunque los montos en dólares son modestos en el contexto de la capitalización de mercado de Upstart, la continua venta por parte de insiders puede atraer la atención de los inversores, especialmente dada la incertidumbre macroeconómica que afecta las valoraciones fintech. El formulario 144 también confirma que el vendedor no posee información material adversa no divulgada, cumpliendo con los requisitos de la Regla 144.

Upstart Holdings, Inc. (UPST)에 대해 제출된 144 양식은 2025년 7월 8일경 Charles Schwab & Co.를 통해 5,000주 보통주 매각을 제안하며, 총 시장 가치는 400,210달러입니다. 해당 주식은 같은 날 직원 주식 옵션의 현금 없는 행사를 통해 취득되었으므로, 신규 주식 발행은 없으며 거래는 희석 효과가 없습니다.

해당 제출서류에는 지난 3개월간 Scott Darling의 내부자 거래 내역이 포함되어 있으며, 총 26,115주를 매도하여 총 수익은 144만 달러입니다. 이번 제안된 거래를 포함하면 내부자 매도 누적 주식 수는 31,115주에 달합니다. 회사의 총 발행 주식 수 9,510만 주 대비 이번 5,000주 매도는 약 0.005%의 유통 주식에 해당하여 유통 주식 수나 유동성에 미치는 영향은 미미합니다.

달러 금액은 Upstart의 시가총액에 비해 적은 편이지만, 지속적인 내부자 매도는 특히 핀테크 평가에 영향을 미치는 거시경제 불확실성 상황에서 투자자들의 관심을 끌 수 있습니다. 144 양식은 또한 판매자가 미공개 중요 부정적 정보를 보유하지 않음을 확인하여 규칙 144 요건을 충족함을 명시합니다.

Le formulaire 144 déposé pour Upstart Holdings, Inc. (UPST) détaille la vente proposée de 5 000 actions ordinaires aux alentours du 08/07/2025 via Charles Schwab & Co., pour une valeur marchande totale de 400 210 $. Les actions ont été acquises le même jour via un exercice sans décaissement d’options d’achat d’actions des employés ; par conséquent, aucune nouvelle action n’a été émise et la transaction n’est pas dilutive.

Le dépôt liste les activités antérieures d’initiés par Scott Darling au cours des trois derniers mois, totalisant 26 115 actions vendues pour un produit brut de 1,44 million de $. En incluant la nouvelle transaction proposée, les ventes cumulées des initiés atteignent 31 115 actions. Par rapport au nombre total d’actions en circulation de 95,1 millions, la vente imminente de 5 000 actions représente environ 0,005 % des actions en circulation, ce qui indique un impact mécanique minimal sur le flottant ou la liquidité.

Bien que les montants en dollars soient modestes dans le contexte de la capitalisation boursière d’Upstart, la poursuite des ventes d’initiés pourrait attirer l’attention des investisseurs, notamment en raison de l’incertitude macroéconomique persistante affectant les valorisations fintech. Le formulaire 144 confirme également que le vendeur ne détient aucune information matérielle défavorable non divulguée, respectant ainsi les exigences de la règle 144.

Das Formular 144 für Upstart Holdings, Inc. (UPST) beschreibt den geplanten Verkauf von 5.000 Stammaktien um den 08.07.2025 herum über Charles Schwab & Co. zu einem Gesamtmarktwert von 400.210 $. Die Aktien wurden am selben Tag durch eine barlose Ausübung von Mitarbeiteraktienoptionen erworben; daher wurden keine neuen Aktien ausgegeben und die Transaktion ist nicht verwässernd.

Die Einreichung listet frühere Insider-Aktivitäten von Scott Darling in den letzten drei Monaten auf, mit insgesamt 26.115 verkauften Aktien und Bruttoerlösen von 1,44 Millionen $. Einschließlich des neu vorgeschlagenen Verkaufs belaufen sich die kumulativen Insider-Verkäufe auf 31.115 Aktien. Im Verhältnis zur ausstehenden Aktienzahl des Unternehmens von 95,1 Millionen entsprechen die bevorstehenden 5.000 Aktien etwa 0,005 % der ausstehenden Aktien, was auf eine minimale mechanische Auswirkung auf den Streubesitz oder die Liquidität hinweist.

Obwohl die Dollarbeträge im Kontext der Marktkapitalisierung von Upstart bescheiden sind, könnte der fortgesetzte Insiderverkauf die Aufmerksamkeit der Investoren auf sich ziehen, insbesondere angesichts der anhaltenden makroökonomischen Unsicherheit, die die Bewertungen im Fintech-Bereich beeinflusst. Das Formular 144 bestätigt zudem, dass der Verkäufer keine nicht offengelegten wesentlichen negativen Informationen besitzt und damit die Anforderungen der Regel 144 erfüllt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Rosner Elimelech

(Last) (First) (Middle)
C/O HEALTHEQUITY, INC.
15 W. SCENIC POINTE DR., STE. 100

(Street)
DRAPER UT 84020

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
HEALTHEQUITY, INC. [ HQY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, CHIEF TECHNOLOGY OFFICER
3. Date of Earliest Transaction (Month/Day/Year)
07/03/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/03/2025 F 2,982 D $100.8721 59,707 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
The Power of Attorney given by Mr. Rosner was previously filed with the U.S. Securities and Exchange Commission on July 7, 2023, as an exhibit to a statement on Form 4 filed by Mr. Rosner with respect to HealthEquity, Inc. and is hereby incorporated by reference.
/s/ Michael Newton, Attorney-in-Fact 07/08/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Upstart (UPST) shares are insiders proposing to sell?

5,000 common shares are scheduled for sale under this Form 144.

What is the total value of the proposed UPST insider sale?

The aggregate market value is approximately $400,210.

How much stock has Scott Darling sold in the last three months?

He sold 26,115 shares for gross proceeds of $1.44 million before this notice.

Will the Form 144 sale dilute existing UPST shareholders?

No. The shares come from option exercises, so no new shares are issued.

What percentage of Upstart’s outstanding shares does the 5,000-share sale represent?

Approximately 0.005% of the outstanding 95.1 million shares.
Healthequity Inc

NASDAQ:HQY

HQY Rankings

HQY Latest News

HQY Latest SEC Filings

HQY Stock Data

8.40B
84.52M
2.14%
106.13%
4.97%
Health Information Services
Services-business Services, Nec
Link
United States
DRAPER